Literature DB >> 28937377

Levels of interleukins 2, 6, 8, and 10 in patients with irritable bowel syndrome.

Shaileshkumar R Patel1, Anshul Singh1, Vatsala Misra1, Sri Prakash Misra2, Manisha Dwivedi2, Pawan Trivedi1.   

Abstract

Irritable bowel syndrome (IBS) was previously considered as a psychosomatic disorder. But recent studies indicate that inflammation plays a significant role. The present study was undertaken to evaluate role of pro-inflammatory (IL 2, IL 6 and IL 8) and anti-inflammatory (IL 10) cytokines in clinically diagnosed patients of IBS. 51 patients and 29 controls were included in this study. On the basis of history of gastrointestinal infection, patients were divided into Post Infectious (PIIBS) and Non Post Infectious (NPIIBS) groups. All subsequently underwent colonoscopy and a rectosigmoid biopsy as well as measurement of levels of IL 2, 6, 8 and 10. The levels of IL 2 and IL 8 were significantly raised in IBS patients compared to controls with the mean level of IL 2,6 and 8 higher in PIIBS group than NPIIBS group but statistically significant for IL 8 only. The mean level IL-10 was reduced in patients compared to controls but statistically insignificant. Present study shows that Interleukin levels are altered in patients suffering from IBS and may have a key role in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28937377     DOI: 10.4103/IJPM.IJPM_544_16

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  5 in total

1.  The CCL28 levels are elevated in the serum of patients with irritable bowel syndrome and associated with the clinical symptoms.

Authors:  Farshad Sheikhesmaili; Ali Jalili; Elmira Taghizadeh; Shohreh Fakhari; Khashaiar Jalili; Ebrahim Ghaderi; Ezatollah Rahimi
Journal:  Am J Clin Exp Immunol       Date:  2021-02-15

2.  Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity.

Authors:  Laura Prospero; Giuseppe Riezzo; Michele Linsalata; Antonella Orlando; Benedetta D'Attoma; Marta Di Masi; Manuela Martulli; Francesco Russo
Journal:  BMC Gastroenterol       Date:  2021-05-22       Impact factor: 3.067

3.  Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report.

Authors:  Gian Paolo Caviglia; Alessandra Tucci; Rinaldo Pellicano; Sharmila Fagoonee; Chiara Rosso; Maria Lorena Abate; Antonella Olivero; Angelo Armandi; Ester Vanni; Giorgio Maria Saracco; Elisabetta Bugianesi; Marco Astegiano; Davide Giuseppe Ribaldone
Journal:  J Clin Med       Date:  2020-07-23       Impact factor: 4.241

4.  Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT.

Authors:  Vladimir T Ivashkin; Elena A Poluektova; Alexey B Glazunov; Mikhail A Putilovskiy; Oleg I Epstein
Journal:  BMC Gastroenterol       Date:  2019-12-31       Impact factor: 3.067

5.  STW 5 Herbal Preparation Modulates Wnt3a and Claudin 1 Gene Expression in Zebrafish IBS-like Model.

Authors:  Monica Piccione; Nicola Facchinello; Sandra Schrenk; Marco Gasparella; Surajit Pathak; Ramy M Ammar; Sabine Rabini; Luisa Dalla Valle; Rosa Di Liddo
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.